You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Boehringer Ingelheim
McKesson
Mallinckrodt
Colorcon

Last Updated: February 20, 2020

DrugPatentWatch Database Preview

Litigation Details for Purdue Pharma L.P. v. Kashiv Pharma, LLC (D. Del. 2018)


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Purdue Pharma L.P. v. Kashiv Pharma, LLC (D. Del. 2018)

Docket   Start Trial Date Filed 2018-01-03
Court District Court, D. Delaware Date Terminated 2018-08-14
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To
Parties KASHIV PHARMA, LLC; PURDUE PHARMA L.P.; PURDUE PHARMACEUTICALS L.P.
Patents 7,674,799; 7,674,800; 7,683,072; 8,114,383; 8,309,060; 8,337,888; 8,808,741; 8,894,987; 8,894,988; 9,060,976; 9,073,933; 9,492,392; 9,492,393; 9,522,919; 9,675,610; 9,763,933; 9,770,416; 9,775,808
Attorneys Anne Shea Gaza; Gasper J. LaRosa; Jack B. Blumenfeld; Jan M. Conlin; John J. Normile; Katie Crosby Lehmann; Kelsey I. Nix; Kenneth S. Canfield; Landon R. Clark; Megan Elizabeth Dellinger; Melissa A. Goodman; Pablo D. Hendler; Rodger Dallery Smith , II; Samantha G. Wilson; Sarah A. Geers
Firms Morris, Nichols, Arsht & Tunnell; Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Purdue Pharma L.P. v. Kashiv Pharma, LLC
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Purdue Pharma L.P. v. Kashiv Pharma, LLC (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2018-01-03 1 15-1152-RGA, for patent infringement of U.S. Patent Nos. 7,674,799 (the “’799 patent”); 7,674,800 (the…United States Patent Nos. 9,763,933 (the “Mannion ’933 patent”)1; 9,770,416 (the “’416 patent”); and 9,775,808…Mannion ’933 patent is different from U.S. Patent No. 9,073,933, which is one of the patents-in-suit asserted… 15-831-RGA, for patent infringement of U.S. Patent Nos. 9,060,976 (the “’976 patent”) and 9,034,376 …the “’800 patent”); 7,683,072 (the “’072 patent”); 8,114,383 (the “’383 patent”); 8,309,060 (the “’060 External link to document
0000-00-00 24 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,763,933; 9,770,416; 9,775,808…2018 14 August 2018 1:18-cv-00052 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
0000-00-00 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,763,933; 9,770,416; 9,775,808…2018 14 August 2018 1:18-cv-00052 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Colorcon
Harvard Business School
Merck
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.